Gene Biotherapeutics, Inc. (CRXM)
Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company. The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease, and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde in December 2003 and is headquartered in San Diego, CA.
Address
11750 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Founded
2003
Number of Employees
-
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)